Table 3.
Prevalence rates of baseline factors in hospitalized patients with ECC
| HCV Ab-positive patients (N=72) | HCV Ab-negative patients (N=783) | p values | |
|---|---|---|---|
| Female, N (%) | 48 (66.7) | 320 (40.8) | 0.009 |
| Age (years) | 62.79±10.44 | 62.35±11.86 | 0.85 |
| BMI (kg/m2) | 24.47±4.34 | 23.19±4.44 | 0.208 |
| DM, N (%) | 18 (25.0) | 169 (21.6) | 0.393 |
| H/T, N (%) | 21 (29.2) | 312 (39.8) | 0.232 |
| Hyperlipidemia, N (%) | 3 (4.2) | 48 (6.1) | 0.594 |
| HU, N (%) | 5 (6.9) | 35 (4.5) | 0.504 |
| ACS, N (%) | 5 (6.9) | 37 (4.7) | 0.569 |
| CVA, N (%) | 3 (4.2) | 37 (4.7) | 0.785 |
| Smoking, N (%) | 5 (6.9) | 185 (23.6) | 0.067 |
| Alcohol, N (%) | 10 (13.8) | 180 (23.0) | 0.457 |
| Betel nut, N (%) | 3 (4.2) | 42 (5.4) | 0.785 |
| HBV infection, N (%) | 10 (13.8) | 74 (9.5) | 0.176 |
N: number; ECC: extrahepatic cholangiocarcinoma; BMI: body mass index; DM: diabetes; H/T: hypertension; DL: dyslipidemia; HU: hyperuricemia; ACS: acute coronary syndrome; CVA: cerebrovascular accident; HBV infection: hepatitis B virus surface antigen positivity.